Zhengdong Cai

Title: Zhengdong Cai: Innovator in Tumor Cell Detection

Introduction

Zhengdong Cai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer detection through his innovative research and patented technologies. His work focuses on the detection of rare tumor cells in body fluid samples, which is crucial for advancing cancer diagnostics.

Latest Patents

Zhengdong Cai holds a patent titled "Use of hexokinase-2 in detection of rare tumor cells in body fluid sample and kit." This patent relates to the use of hexokinase-2 (HK2) as a marker for detecting rare tumor cells based on their abnormal energy metabolism. The method allows for the identification of circulating tumor cells, particularly those with high glycolysis activity, providing a more effective approach than traditional detection methods that rely on epithelial markers. This innovation offers a technical basis for improved applications of cancer liquid biopsy in clinical settings.

Career Highlights

Throughout his career, Zhengdong Cai has worked with notable companies such as Suzhou Junhui Biotechnology Co., Ltd. and Hangzhou Junhui Biotechnology Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and cancer research.

Collaborations

Zhengdong Cai has collaborated with professionals like Liu Yang and Yingqi Hua, enhancing his research and development efforts in the field of tumor detection.

Conclusion

Zhengdong Cai's innovative work in the detection of rare tumor cells represents a significant advancement in cancer diagnostics. His patented technology has the potential to improve clinical outcomes for cancer patients through more accurate detection methods.